CLPBY (Coloplast AS) Price-to-Tangible-Book: (As of Aug. 04, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CLPBY Coloplast AS CLPBY
77 GF Score
Price $6.71
GF Value $13.05
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is Coloplast AS Price-to-Tangible-Book?

As of today (2026-08-04), Coloplast AS's share price is $6.71. Coloplast AS's Tangible Book per Share of Mar. 2026 for the quarter that ended in Mar. 2026 was $-1.00. Hence, Coloplast AS's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Coloplast AS's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, Coloplast AS's highest Price to Tangible Book Ratio was 89.34. The lowest was 29.65. And the median was 45.56.

CLPBY's Price-to-Tangible-Book is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.63
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Coloplast AS's share price is $6.71. Coloplast AS's Book Value per Sharefor the quarter that ended in Mar. 2026 was $0.88. Hence, Coloplast AS's P/B Ratio of today is 7.62.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Coloplast AS Price-to-Tangible-Book Related Terms

Coloplast AS Price-to-Tangible-Book Historical Data

* Premium members only.

The historical data trend for Coloplast AS's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coloplast AS Price-to-Tangible-Book Chart

Coloplast AS Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 46.58 0.00 0.00 0.00 0.00

Coloplast AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CLPBY vs ISRG, BDX, MDLN: Price-to-Tangible-Book Comparison

For the Medical Instruments & Supplies subindustry, Coloplast AS's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Coloplast AS Price-to-Tangible-Book vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Coloplast AS's Price-to-Tangible-Book falls into.


CLPBY
77GF Score
Coloplast AS CLPBY
Price-to-Tangible-Book is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Coloplast AS Price-to-Tangible-Book Calculation

Coloplast AS's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2026 )
=6.71/-1.004
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price to Tangible Book=Market Cap/Tangible Equity
=Market Cap/(Total Stockholders Equity-Preferred Stock-Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Is Coloplast AS (CLPBY) Overvalued in 2026?

Based on GuruFocus' analysis, Coloplast AS stock appears to be undervalued. The current stock price of $6.71 is trading 48.6% below its estimated GF Value™ of $13.05. GuruFocus considers Coloplast AS to be Significantly Undervalued.

Key valuation signals for CLPBY:

  • Price-to-Tangible-Book:
  • GF Value™: $13.05 vs. price of $6.71 (48.6% below fair value)
  • GF Score™: 77/100 with 6 warning signs

No single metric tells the full story. See the CLPBY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Coloplast AS Business Description

Address Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, intermittent catheters for continence care, and devices for patients with neck stomas. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
77GF Score

Get the complete analysis for CLPBY

Price-to-Tangible-Book is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.71
Price
$13.05
GF Value